Early Versus Late Physiotherapy Following Arthroscopic Repair of Small and Medium Size Rotator Cuff Tear: A Randomized Clinical Trial Publisher Pubmed



Guity MR¹ ; Mirghaderi P^{1, 2} ; Mortazavi SJ¹ ; Malek M³ ; Moharrami A¹ ; Bagheri N⁴ ; Sharifpour S¹ Show Affiliations
Source: International Orthopaedics Published:2023

Abstract

Purpose: We compared early and late physiotherapy for patients with small and medium size rotator cuff tears following arthroscopic repair. Methods: A single-centre, single-blinded, prospective parallel RCT was performed with two arms: early physiotherapy (start within the first week) versus late physiotherapy (start 4 weeks after surgery). Patients with small- to medium-sized isolated full-thickness superior rotator cuff tears were included and followed for 12 months. The primary outcome measures were shoulder function and range of motion (ROM) measured by the Constant-Murley score (CMS) at three months, six months, and 12 months. The other outcomes were the visual analog scale (VAS) pain and the rotator cuff ultrasound (US) evaluation by the Sugaya classification. Results: In three and six month follow-ups, CMS was significantly superior in the intervention group compared to controls (P < 0.05). However, only at the three month follow-up between-group difference met the minimal clinically important difference (MCID) (MCID = 10.4) (59.8 vs. 48.9). The intervention group experienced less pain than controls in the first six months (P < 0.001), and only the three month follow-up was clinically meaningful based on MCID (MCID = 1.4). Moreover, in the first six months, the shoulder ROM favoured the intervention group (P < 0.05). US grading of the supraspinatus and infraspinatus was similar between groups (P = 0.07). One retear occurred in the intervention group and another in the controls, detected by examination and US evaluation. Conclusion: Following the arthroscopic repair of a small- to medium-sized rotator cuff tear, early physiotherapy showed promising results for pain, function, and range of motion. Level of evidence: Level I therapeutic. © 2023, The Author(s) under exclusive licence to SICOT aisbl.